Retraction. “Phase II study of the anti–insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer”
J Clin Oncol. 2012 Nov 20;30(33):4179.
doi: 10.1200/jco.2012.47.3447.